RU2019116786A3 - - Google Patents

Download PDF

Info

Publication number
RU2019116786A3
RU2019116786A3 RU2019116786A RU2019116786A RU2019116786A3 RU 2019116786 A3 RU2019116786 A3 RU 2019116786A3 RU 2019116786 A RU2019116786 A RU 2019116786A RU 2019116786 A RU2019116786 A RU 2019116786A RU 2019116786 A3 RU2019116786 A3 RU 2019116786A3
Authority
RU
Russia
Application number
RU2019116786A
Other versions
RU2019116786A (ru
RU2765695C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2019116786A publication Critical patent/RU2019116786A/ru
Publication of RU2019116786A3 publication Critical patent/RU2019116786A3/ru
Application granted granted Critical
Publication of RU2765695C2 publication Critical patent/RU2765695C2/ru

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00Apparatus for enzymology or microbiology
    • C12M1/34Measuring or testing with condition measuring or sensing means, e.g. colony counters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20Supervised data analysis
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Databases & Information Systems (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Bioethics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Evolutionary Computation (AREA)
  • Software Systems (AREA)
  • Artificial Intelligence (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Sustainable Development (AREA)
  • Primary Health Care (AREA)
RU2019116786A 2016-10-31 2017-10-31 Устройство определения поражения заболеванием, способ определения поражения заболеванием и программа определения поражения заболеванием RU2765695C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2016-213690 2016-10-31
JP2016213690 2016-10-31
PCT/JP2017/039363 WO2018079840A1 (ja) 2016-10-31 2017-10-31 疾患の罹患判定装置、疾患の罹患判定方法及び疾患の罹患判定プログラム

Publications (3)

Publication Number Publication Date
RU2019116786A RU2019116786A (ru) 2020-11-30
RU2019116786A3 true RU2019116786A3 (ru) 2020-11-30
RU2765695C2 RU2765695C2 (ru) 2022-02-02

Family

ID=61195694

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019116786A RU2765695C2 (ru) 2016-10-31 2017-10-31 Устройство определения поражения заболеванием, способ определения поражения заболеванием и программа определения поражения заболеванием

Country Status (6)

Country Link
US (1) US20190267113A1 (ru)
EP (1) EP3534281A4 (ru)
JP (3) JP6280997B1 (ru)
CN (1) CN109923614A (ru)
RU (1) RU2765695C2 (ru)
WO (1) WO2018079840A1 (ru)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010242036A1 (en) 2009-04-30 2011-11-03 Patientslikeme, Inc. Systems and methods for encouragement of data submission in online communities
US11250340B2 (en) * 2017-12-14 2022-02-15 Microsoft Technology Licensing, Llc Feature contributors and influencers in machine learned predictive models
JP6879239B2 (ja) * 2018-03-14 2021-06-02 オムロン株式会社 異常検知システム、サポート装置およびモデル生成方法
WO2020008502A1 (ja) * 2018-07-02 2020-01-09 シンセティックゲシュタルト エルティーディー 情報処理システム、情報処理装置、サーバ装置、プログラム、又は方法
JP7362241B2 (ja) * 2018-11-02 2023-10-17 公益財団法人がん研究会 大腸がんの検査方法
US11151420B2 (en) * 2018-11-19 2021-10-19 International Business Machines Corporation Determination using learned model
EP3865872A4 (en) 2018-11-19 2022-08-10 Canon Kabushiki Kaisha INFORMATION PROCESSING DEVICE, METHOD FOR CONTROLLING AN INFORMATION PROCESSING DEVICE, PROGRAM, CALCULATION DEVICE AND CALCULATION METHOD
US11894139B1 (en) * 2018-12-03 2024-02-06 Patientslikeme Llc Disease spectrum classification
CN110211690A (zh) * 2019-04-19 2019-09-06 平安科技(深圳)有限公司 疾病风险预测方法、装置、计算机设备及计算机存储介质
JPWO2020222287A1 (ru) * 2019-04-29 2020-11-05
JP6884810B2 (ja) * 2019-05-08 2021-06-09 キユーピー株式会社 情報提供装置、情報提供方法及びmiRNA重要度テーブル生成方法
CN110338843A (zh) * 2019-08-02 2019-10-18 无锡海斯凯尔医学技术有限公司 组织评价方法、装置、设备及计算机可读存储介质
CN110327074A (zh) * 2019-08-02 2019-10-15 无锡海斯凯尔医学技术有限公司 肝脏评价方法、装置、设备及计算机可读存储介质
JP7412150B2 (ja) * 2019-11-29 2024-01-12 東京エレクトロン株式会社 予測装置、予測方法及び予測プログラム
JP7452990B2 (ja) * 2019-11-29 2024-03-19 東京エレクトロン株式会社 異常検知装置、異常検知方法及び異常検知プログラム
WO2021142417A2 (en) * 2020-01-10 2021-07-15 Bisquertt Alejandro Systems for detecting alzheimer's disease
CN111312401B (zh) * 2020-01-14 2021-12-17 之江实验室 一种基于多标签学习的体检后慢性疾病预后系统
JP7551096B2 (ja) 2020-03-31 2024-09-17 国立大学法人神戸大学 酵素反応阻害パターンが疾患のバイオマーカーとして利用できるかを調べる方法および装置、並びに、疾患検査装置
US11468276B2 (en) * 2020-04-16 2022-10-11 Robert Bosch Gmbh System and method of a monotone operator neural network
CN111696662A (zh) * 2020-05-26 2020-09-22 平安科技(深圳)有限公司 疾病预测方法、装置及存储介质
CN112530595A (zh) * 2020-12-21 2021-03-19 无锡市第二人民医院 一种基于多分支链式神经网络的心血管疾病分类方法和装置
CN112685561A (zh) * 2020-12-26 2021-04-20 广州知汇云科技有限公司 一种跨病种的小样本临床医疗文本后结构化处理方法
EP4411742A1 (en) * 2021-09-29 2024-08-07 FUJIFILM Corporation Measurable and preferable feature selection method, program for selecting measurable and preferable feature, and measurable and preferable feature selection device
JP7374424B2 (ja) * 2021-11-30 2023-11-07 ダイキン工業株式会社 疾病あるいは健康状態の検査方法、及び検査システム
CN114613438B (zh) * 2022-03-08 2023-05-26 电子科技大学 一种miRNA与疾病的关联预测方法及系统
KR20240092770A (ko) * 2022-12-15 2024-06-24 한국과학기술원 우울증 예측을 위한 인공지능 및 웹 기반 플랫폼
CN116578711B (zh) * 2023-07-06 2023-10-27 武汉楚精灵医疗科技有限公司 腹痛特征提取方法、装置、电子设备及存储介质
CN118609668A (zh) * 2024-06-25 2024-09-06 云鉴康(杭州)医疗科技有限公司 基于深度学习质谱分类方法、生物标志物发现方法及装置

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1194045A (zh) * 1995-07-25 1998-09-23 好乐思治疗公司 计算机辅助疾病诊断方法
EP0879449A2 (en) * 1996-02-09 1998-11-25 Adeza Biomedical Corporation Method for selecting medical and biochemical diagnostic tests using neural network-related applications
JP3525082B2 (ja) * 1999-09-16 2004-05-10 日本電信電話株式会社 統計モデル作成方法
JP2003006329A (ja) * 2001-06-26 2003-01-10 Hitachi Ltd 診断支援システム
JP3823192B2 (ja) * 2002-04-19 2006-09-20 学校法人慶應義塾 診療支援装置、診療支援方法、及び診療支援プログラム
US7774143B2 (en) * 2002-04-25 2010-08-10 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Methods for analyzing high dimensional data for classifying, diagnosing, prognosticating, and/or predicting diseases and other biological states
US20040219575A1 (en) * 2002-12-26 2004-11-04 Toomas Neuman Methods and compositions for the diagnosis, prognosis, and treatment of cancer
EP1633234A4 (en) * 2003-06-03 2009-05-13 Physiosonics Inc SYSTEMS AND METHODS FOR DETERMINING INTRACRANIAL FA NON-INVASIVE PRESSURE AND ACOUSTIC TRANSDUCER ASSEMBLIES FOR USE THEREIN
CA2531967C (en) * 2003-07-10 2013-07-16 Genomic Health, Inc. Expression profile algorithm and test for cancer prognosis
JP5038671B2 (ja) * 2006-09-25 2012-10-03 株式会社東芝 検査項目選定装置、検査項目選定方法、及び検査項目選定プログラム
RU2473555C2 (ru) * 2006-12-19 2013-01-27 ДжинГоу, Инк. Новые способы функционального анализа большого количества экспериментальных данных и групп генов, идентифицированных из указанных данных
FI20070159A0 (fi) * 2007-02-23 2007-02-23 Teknillinen Korkeakoulu Menetelmä informaation integrointiin, valintaan ja esityksen oppimiseen
US20120143805A1 (en) * 2008-09-09 2012-06-07 Somalogic, Inc. Cancer Biomarkers and Uses Thereof
CA3011730C (en) * 2008-09-09 2022-05-17 Somalogic, Inc. Lung cancer biomarkers and uses thereof
GB2463401B (en) * 2008-11-12 2014-01-29 Caris Life Sciences Luxembourg Holdings S A R L Characterizing prostate disorders by analysis of microvesicles
EP2239675A1 (en) * 2009-04-07 2010-10-13 BIOCRATES Life Sciences AG Method for in vitro diagnosing a complex disease
CN101901345B (zh) * 2009-05-27 2013-02-27 复旦大学 一种差异蛋白质组学的分类方法
JP2013515270A (ja) * 2009-12-22 2013-05-02 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 前立腺癌の代謝学的プロファイリング
EP2354246A1 (en) * 2010-02-05 2011-08-10 febit holding GmbH miRNA in the diagnosis of ovarian cancer
JP2012051822A (ja) * 2010-08-31 2012-03-15 Institute Of Physical & Chemical Research 肺癌診断用ポリペプチド、肺癌の検出方法、および治療効果の評価方法
JP5637373B2 (ja) * 2010-09-28 2014-12-10 株式会社Screenホールディングス 画像の分類方法、外観検査方法および外観検査装置
CA2830602A1 (en) * 2011-03-22 2012-09-27 Thomas J. Fahey, Iii Distinguishing benign and malignant indeterminate thyroid lesions
JP5645761B2 (ja) * 2011-06-23 2014-12-24 登史夫 小林 医療データ解析方法、医療データ解析装置およびプログラム
CN104677999A (zh) * 2013-11-29 2015-06-03 沈阳药科大学 血浆用于区分肝癌与肺癌的生物标记物
EP4137586A1 (en) * 2014-08-07 2023-02-22 Agency for Science, Technology and Research Microrna biomarker for the diagnosis of gastric cancer
CN105243296A (zh) * 2015-09-28 2016-01-13 丽水学院 联合mRNA和microRNA表达谱芯片的肿瘤特征基因选择方法
CN105701365B (zh) * 2016-01-12 2018-09-07 西安电子科技大学 发现癌症相关基因的方法及相关系统、药物制备方法
CN105550715A (zh) * 2016-01-22 2016-05-04 大连理工大学 一种基于近邻传播聚类的集成分类器构建方法

Also Published As

Publication number Publication date
EP3534281A4 (en) 2020-06-03
RU2019116786A (ru) 2020-11-30
CN109923614A (zh) 2019-06-21
JP6280997B1 (ja) 2018-02-14
RU2765695C2 (ru) 2022-02-02
US20190267113A1 (en) 2019-08-29
JP2022024092A (ja) 2022-02-08
EP3534281A1 (en) 2019-09-04
JP7411619B2 (ja) 2024-01-11
JP7021097B2 (ja) 2022-02-16
WO2018079840A1 (ja) 2018-05-03
JPWO2018079840A1 (ja) 2019-09-19
JP2018077814A (ja) 2018-05-17

Similar Documents

Publication Publication Date Title
RU2019116786A3 (ru)
BR122021017409A2 (ru)
BR112019009265A2 (ru)
JP1586171S (ru)
JP1606095S (ru)
JP1578391S (ru)
BR102016014616A2 (ru)
CN303541954S (ru)
CN303542739S (ru)
CN303537828S (ru)
CN303538171S (ru)
CN303539371S (ru)
CN303539471S (ru)
CN303539854S (ru)
CN303540702S (ru)
CN303544603S (ru)
CN303541245S (ru)
CN303541432S (ru)
CN303550688S (ru)
CN303541474S (ru)
CN303541522S (ru)
CN303541635S (ru)
CN303541676S (ru)
CN303541743S (ru)
CN303536269S (ru)